$11.90
-0.78[-6.15%]
At close: May 2
$11.90
0[0.00%]
After Hours: 7:48PM EDT
Cidara Therapeutics
(NASDAQ:CDTX)Latest News for Cidara Therapeutics Stock (NASDAQ:CDTX)
Cidara Therapeutics Stock (NASDAQ: CDTX)
Categories: All
Thursday, April 25, 2024
- WBB Securities Maintains Strong Buy on Cidara Therapeutics, Adjusts Price Target To $40 (reverse stock split - 1:20)Benzinga Newsdesk - Apr 25, 2024, 3:30PM
- Needham Maintains Buy on Cidara Therapeutics, Adjusts Price Target To $25Benzinga Newsdesk - Apr 25, 2024, 2:23PM
- Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Apr 25, 2024, 1:57PM
- Cantor Fitzgerald Reiterates Overweight on Cidara TherapeuticsBenzinga Newsdesk - Apr 25, 2024, 10:32AM
- Market-Moving News for April 25thBenzinga Newsdesk - Apr 25, 2024, 8:31AM
- Cidara Therapeutics shares are trading higher after the company announced the divestiture of rezafungin to Mundipharma, reacquired global development and commercial rights to CD388 and announced $240 million in private placement financing.Benzinga Newsdesk - Apr 25, 2024, 6:13AM
- Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Apr 25, 2024, 6:12AM
Wednesday, April 24, 2024
- Cidara Therapeutics shares are trading higher after the company announced the divestiture of rezafungin to Mundipharma, reacquired global development and commercial rights to CD388 and announced $240 million in private placement financing.Benzinga Newsdesk - Apr 24, 2024, 4:53PM
- Cidara Therapeutics Reacquires Global Development And Commercial Rights To CD388 From Johnson & Johnson For A One Time Payment Of $85M; Announces Private Placement Financing Of $240MBenzinga Newsdesk - Apr 24, 2024, 4:47PM
- Cidara Therapeutics Announces Divestiture Of Rezafungin To Mundipharma To Focus On Advancing The Clinical Development Of Cloudbreak DFC Pipeline; Transaction Provides Company With An Estimated ~$128M In Cost SavingsBenzinga Newsdesk - Apr 24, 2024, 4:46PM
- Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - Apr 24, 2024, 8:55AM
Tuesday, April 23, 2024
- Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - Apr 23, 2024, 7:50PM
- Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Apr 23, 2024, 1:53PM
- Cantor Fitzgerald Reiterates Overweight on Cidara TherapeuticsBenzinga Newsdesk - Apr 23, 2024, 8:54AM
- Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Apr 23, 2024, 8:00AM
Monday, April 22, 2024
- Cidara Therapeutics Q4 EPS $(0.04) Beats $(0.10) Estimate, Sales $17.58M Beat $11.54M EstimateBenzinga Newsdesk - Apr 22, 2024, 5:12PM
- Cidara Therapeutics Announces Receipt Of Nasdaq Delinquency NoticeBenzinga Newsdesk - Apr 22, 2024, 5:08PM
- Why Cidara Therapeutics (CDTX) Stock Is FallingHenry Khederian - Apr 22, 2024, 3:52PM
- Cidara Therapeutics shares are trading lower. The company announced a 1-for-20 reverse stock split.Benzinga Newsdesk - Apr 22, 2024, 10:37AM
- Cidara Therapeutics Announces 1-For-20 Reverse Stock Split, Will Begin Trading On A Split-Adjusted Basis Commencing Upon Market Open On April 24, 2024Benzinga Newsdesk - Apr 22, 2024, 8:50AM
Monday, April 08, 2024
Friday, April 05, 2024
Wednesday, March 06, 2024
Wednesday, February 14, 2024
Monday, February 12, 2024
Tuesday, January 30, 2024
Monday, January 29, 2024
- Cidara Therapeutics shares are trading higher after the company announced the approval of REZZAYO by the MHRA for the treatment of invasive candidiasis in adults.Benzinga Newsdesk - Jan 29, 2024, 4:59PM
- Cidara Therapeutics Announces Approval Of REZZAYO By The MHRA For The Treatment Of Invasive Candidiasis In AdultsBenzinga Newsdesk - Jan 29, 2024, 4:36PM
Monday, December 25, 2023
Friday, December 22, 2023
Thursday, December 07, 2023
- Cidara Therapeutics Presents New Promising Preclincal Data On Novel Dual-Acting Drug-Fc Conjugates At ESMO Immuno-Oncology Annual CongressBenzinga Newsdesk - Dec 7, 2023, 8:05AM
- HC Wainwright & Co. Reiterates Buy on Cidara Therapeutics, Maintains $6 Price TargetBenzinga Newsdesk - Dec 7, 2023, 6:39AM
Wednesday, December 06, 2023
Thursday, November 30, 2023
Monday, November 06, 2023
Friday, November 03, 2023
Thursday, November 02, 2023
Friday, October 13, 2023
Wednesday, October 11, 2023
Friday, September 22, 2023
Friday, September 08, 2023
Thursday, September 07, 2023
Wednesday, September 06, 2023
- Crude Oil Rises Over 1%; Cidara Therapeutics Shares Spike HigherLisa Levin - Sep 6, 2023, 2:41PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Sep 6, 2023, 1:31PM
- Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Sep 6, 2023, 1:16PM
- Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today?Vandana Singh - Sep 6, 2023, 11:26AM
- Cidara Therapeutics shares are trading higher after Janssen elected to proceed under its license agreement relating to influenza candidate.Benzinga Newsdesk - Sep 6, 2023, 10:01AM
- Cidara Therapeutics Announces Janssen's Election To Proceed Under Its License Agreement Relating To Novel Drug-Fc Conjugates Targeting Influenza; Co. To Receive A $7M Milestone Payment And Is eligible For Additional $685MBenzinga Newsdesk - Sep 6, 2023, 8:03AM